Kendle

Martha R. Feller, Ph.D., has rejoined Kendle as vice president and global head, study start-up, effective immediately. In her new role, Dr. Feller will provide leadership for the company’s global study start-up function, including study start-up management, site identification, site start-up, clinical trial regulatory, investigator contracts and essential document collection. She will focus on fostering site relationships to optimize timelines and deliver rapid study start-up for global clinical trials.

Dr. Feller has more than 30 years of senior operations leadership in the clinical development industry, including broad therapeutic expertise and experience managing large-scale, global development programs. Dr. Feller recently served as executive vice president of global operations at i3 Research, where she was responsible for Phase I-III programs. From 2004 to 2009, Dr. Feller held leadership roles in Kendle’s Phase II-III development operations, serving most recently as senior vice president of global clinical development.

“Timely and efficient study start-up on global projects is essential to our business success and ability to deliver best-in-class clinical development solutions to our customers,” said Stephen Cutler, Ph.D., senior vice president and chief operating officer. “The appointment of an experienced industry veteran to lead this important function demonstrates our commitment to delivery of site selection and start-up strategies that provide valuable time-saving results for our customers.”